Dermal Fillers Market
Dermal fillers are anti-aging products injected into patients’ skin to enhance volume. Dermal fillers help in transforming sagging skin or skin that has wrinkled due to aging into smooth and plump skin. These fillers are made of hyaluronic acid extracted from animals or derived from the fat of the patient. It takes five minutes to an hour to complete a dermal filler procedure. The use of intradermal fillers can be combined into dermatological practices with minimum overhead costs. This strategy focuses on facial volume loss and dynamic lines, which are the principal features of facial aging. The growing preference for minimally invasive procedures and the rising attraction of consumers toward beauty and wellness are noteworthy factors contributing to the expansion of the dermal fillers market size. On the other hand, the high cost of dermal filler procedures hinders market growth. Moreover, growing adoption of combination therapies is expected to bring new dermal fillers market trends in the coming years.
Increasing Preference for Minimally Invasive Procedures Drives Dermal Fillers Market Growth
Minimally invasive procedures have gained popularity among consumers, as they offer various advantages over traditional surgical methods. These procedures involve less risk, minimal scarring, shorter recovery times, and often require only local anesthesia. Additionally, advancements in cosmetic techniques have made dermal fillers more effective and safer than ever before. Newer formulations of fillers are longer-lasting and provide more natural-looking results. This has increased consumer confidence in these procedures and contributed to their growing popularity.
According to the statistics from the Aesthetic Society, 649,176 filler procedures were performed in the US in 2022, and dermal filler procedures accounted for 14% of the total non-surgical revenue in the US in 2022. This makes it the third most common non-surgical aesthetic procedure in 2022. Similarly, according to the Global Survey 2022 report by the International Society of Aesthetic Plastic Surgery, the total number of non-surgical and surgical aesthetic procedures increased by 11.2% in 2022 compared to 2021, with more than 14.9 million surgical and 18.8 million non-surgical procedures performed worldwide.
Furthermore, age plays a substantial role in determining the unique needs of medical aesthetic procedures; adults are more inclined toward minimally invasive approaches. Furthermore, people aged 35–55 have a preference for minimally invasive cosmetic procedures over surgery. Plastic surgeons are increasingly interested in exploring them, and minimally invasive cosmetic and aesthetic procedures are now considered interdisciplinary. The advancement of non-surgical technologies and new treatment alternatives has made aesthetics more accessible to a wider population. Patients in their 20s and 30s are driving this trend.
Overall, the benefits and accuracy offered by minimally invasive procedures compared to traditional surgery are expected to continue to propel the market growth during the forecast period. The ever-increasing interest in retaining a youthful appearance has facilitated various minimally invasive dermatological techniques. The field of cosmetic dermatology has been expanding globally. With the ever-increasing popularity of non-surgical enhancement and an increasing number of patients who have been treated, the demand for fillers continues to rise, boosting the dermal fillers market growth.
Dermal Fillers Market: Segmental Overview
The dermal fillers market is categorized into product, material, application, and end user. In terms of end user, the market is segmented into multispecialty hospitals, dermatology clinics, ambulatory surgical centers, and others. The dermatology clinics segment held a significant dermal fillers market share in 2023 and is estimated to register the highest CAGR during 2023–2031. Patients with specialized dermatology treatment needs tend to visit dermatology clinics for rapid and effective services. These patients usually have specific skin or hair conditions that require expert evaluation and management. Dermatologists help diagnose and treat issues such as acne, eczema, psoriasis, and aging skin. Dermal filler treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin or hair problems. Dermatologists’ expertise and specialized knowledge in diagnosing and treating skin conditions stand as one of the primary advantages of receiving dermal filler treatments at dermatology clinics. Furthermore, a rise in the prevalence of acne and scars across the world, coupled with an increasing number of clinics offering dermal filler treatment, has led to an upsurge in the number of patients visiting dermatology clinics.
Dermal Fillers Market: Competitive Landscape and Key Developments
AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KGaA, Suneva Medical, Bioxis Pharmaceuticals, Bioplus Co. Ltd., Teoxane Laboratories, Bioha Laboratories, Prollenium Medical Technologies, and Sinclair Pharma Ltd are a few key companies operating in the market. These companies focus on product innovation strategies to meet evolving customer demands, along with maintaining their brand name in the dermal fillers market.
As per company press releases, a few recent developments initiated in the global dermal fillers market report are mentioned below:
- In January 2023, Allergan Aesthetics, an AbbVie company, announced the national launch of JUVÉDERM VOLUX XC. The long-lasting hyaluronic acid filler is now available at aesthetic practices for consumers above the age of 21 with moderate to serious loss of jawline definition.
- In May 2021, Sinclair Pharma introduced a new hyaluronic acid facial filler called MaiLi. MaiLi is the first OxiFree technology patented in the world, which retains long molecule HA chains.
- In February 2021, Galderma announced that the US FDA had approved Restylane Defyne for the augmentation and correction of minor to moderate chin retrusion for adults aged 21 and above. Restylane Defyne is the only FDA-approved filler designed to be used in the chin that is produced using the company’s unique manufacturing process. XpresHAn Technology produces a smooth, injectable gel that integrates into the skin for natural and dynamic movement.
- In February 2021, Merz Aesthetics launched BELOTERO BALANCE (+), the lidocaine formulation of BELOTERO BALANCE in the US. BELOTERO BALANCE is a hyaluronic acid filler for etched-in lines that gives a flawless finish for filler patients.
- In October 2020, Allergan Aesthetics, entered into an agreement with Luminera, a privately held aesthetics company, with a collection and pipeline of dermal filler products. Under the terms of the agreement, Allergan Aesthetics acquired Luminera’s complete dermal filler portfolio and R&D pipeline, which further enhanced Allergan Aesthetics’ leading dermal filler portfolio with its JUVDERM portfolio of fillers.
